[go: up one dir, main page]

DK1052975T3 - Propofolsammensætning indeholdende sulfit - Google Patents

Propofolsammensætning indeholdende sulfit

Info

Publication number
DK1052975T3
DK1052975T3 DK99905958T DK99905958T DK1052975T3 DK 1052975 T3 DK1052975 T3 DK 1052975T3 DK 99905958 T DK99905958 T DK 99905958T DK 99905958 T DK99905958 T DK 99905958T DK 1052975 T3 DK1052975 T3 DK 1052975T3
Authority
DK
Denmark
Prior art keywords
composition containing
containing sulfite
propofol composition
propofol
sulfite
Prior art date
Application number
DK99905958T
Other languages
English (en)
Inventor
Dorla Mirejovsky
Liananingsih Tanudarma
Dilip Ashtekar
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Application granted granted Critical
Publication of DK1052975T3 publication Critical patent/DK1052975T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99905958T 1998-02-10 1999-02-10 Propofolsammensætning indeholdende sulfit DK1052975T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2167198A 1998-02-10 1998-02-10
PCT/US1999/003036 WO1999039696A1 (en) 1998-02-10 1999-02-10 Propofol composition containing sulfite

Publications (1)

Publication Number Publication Date
DK1052975T3 true DK1052975T3 (da) 2007-12-27

Family

ID=21805509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905958T DK1052975T3 (da) 1998-02-10 1999-02-10 Propofolsammensætning indeholdende sulfit

Country Status (17)

Country Link
US (2) US6147122A (da)
EP (1) EP1052975B1 (da)
JP (1) JP2002502811A (da)
AR (1) AR015516A1 (da)
AT (1) ATE370726T1 (da)
AU (1) AU750040B2 (da)
BR (1) BR9907832A (da)
CA (1) CA2319810C (da)
CO (1) CO4810371A1 (da)
CY (1) CY1106970T1 (da)
DE (1) DE69936911T2 (da)
DK (1) DK1052975T3 (da)
ES (1) ES2292233T3 (da)
NZ (1) NZ505948A (da)
PE (1) PE20000264A1 (da)
PT (1) PT1052975E (da)
WO (1) WO1999039696A1 (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE252889T1 (de) 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
EP1292282A2 (en) 2000-06-16 2003-03-19 RTP Pharma Inc. Improved injectable dispersions of propofol
IN188917B (da) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
WO2002051411A1 (fr) * 2000-12-22 2002-07-04 Yamanouchi Pharmaceutical Co., Ltd. Injections de famotidine
JP4127757B2 (ja) * 2001-08-21 2008-07-30 株式会社エヌ・ティ・ティ・ドコモ 無線通信システム、通信端末装置、及びバースト信号送信方法
RU2315037C2 (ru) * 2002-01-25 2008-01-20 Тереванс, Инк. Замещенные эфиры фенилуксусной кислоты в качестве короткодействующих седативных снотворных агентов для кратковременной анестезии и создания седативного эффекта, промежуточное соединение, фармацевтическая композиция и применение
EP1492544A4 (en) * 2002-04-08 2005-10-12 Guilford Pharm Inc PHARMACEUTICAL COMPOSITIONS CONTAINING PROPOFOL-BASED WATER-SOLUBLE PRODRUGS AND METHODS OF ADMINISTRATION THEREOF
JP4290381B2 (ja) * 2002-04-11 2009-07-01 学校法人 聖マリアンナ医科大学 ピリドンカルボン酸化合物含有エマルション
US20040171691A1 (en) * 2002-10-29 2004-09-02 Transform Pharmaceuticals, Inc. Propofol with cysteine
DK1585548T3 (da) 2002-12-09 2018-09-03 Abraxis Bioscience Llc Sammensætninger og fremgangsmåder til afgivelse af farmakologiske midler
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
DK1648413T3 (da) * 2003-07-23 2010-01-11 Theravance Inc Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
US20070213411A1 (en) * 2003-11-05 2007-09-13 The Australian National University Dispersions And Methods Of Preparing Them
JP2007520555A (ja) * 2004-02-05 2007-07-26 バクスター・インターナショナル・インコーポレイテッド 自己安定化剤の使用により調製された分散剤
NZ549016A (en) 2004-02-13 2012-03-30 Bioavailability Inc A microemulsion preparation of high concentration propofol for anesthetic uses
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
EP1850829A4 (en) * 2005-02-03 2012-12-26 Taro Pharmaceuticals Usa Inc NEW PROPOLFOL COMPOSITION WITH ASCORBIC ACID OR PHARMACEUTICALLY USEFUL SALTS
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
US20090131538A1 (en) * 2005-05-27 2009-05-21 Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
AU2006310113A1 (en) 2005-08-05 2007-05-10 Bharat Serums & Vaccines Ltd. Intravenous propofol emulsion compositions having preservative efficacy
CN101287447B (zh) * 2005-08-12 2012-10-24 印度血清及疫苗有限公司 包含丙泊酚的水性麻醉剂组合物
HUE042678T2 (hu) 2005-08-31 2019-07-29 Abraxis Bioscience Llc Vízben rosszul oldódó gyógyszerhatóanyagok és antimikrobiális szerek
US8034765B2 (en) 2005-08-31 2011-10-11 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
US20070092464A1 (en) * 2005-10-25 2007-04-26 Duff Rocky J Betadine neutralizer
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US9132090B2 (en) 2009-01-13 2015-09-15 Chetan Majmudar Propofol based anesthetic with preservative
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
HUE026295T2 (en) 2010-10-12 2016-06-28 The Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
IN2014DN10322A (da) 2012-05-16 2015-08-07 Mewa Singh
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法
JP6827029B2 (ja) * 2015-07-03 2021-02-10 オキンス エレクトロニクス カンパニー リミテッド テストソケット、テストソケットの製造方法、およびテストソケット用治具アセンブリー
US10821087B2 (en) 2015-07-24 2020-11-03 Neon Laboratories Limited Stabilized injectable emulsion of Propofol and Ketamine
WO2017031261A1 (en) 2015-08-20 2017-02-23 Mewa Singh Polyphenolic polymer to make water-insoluble molecules become water-soluble
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE69227561T2 (de) * 1991-08-21 1999-06-02 Eisai Co., Ltd., Tokio/Tokyo Kondensierte Pyrimidinderivate als Antitumorverbindungen
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
ES2292233T3 (es) 2008-03-01
CA2319810A1 (en) 1999-08-12
US6147122A (en) 2000-11-14
AU2599199A (en) 1999-08-23
BR9907832A (pt) 2000-10-31
NZ505948A (en) 2003-10-31
CO4810371A1 (es) 1999-06-30
CA2319810C (en) 2008-12-23
DE69936911D1 (de) 2007-10-04
EP1052975B1 (en) 2007-08-22
DE69936911T2 (de) 2008-05-15
AU750040B2 (en) 2002-07-11
EP1052975A1 (en) 2000-11-22
WO1999039696A1 (en) 1999-08-12
US6469069B1 (en) 2002-10-22
AR015516A1 (es) 2001-05-02
JP2002502811A (ja) 2002-01-29
PT1052975E (pt) 2007-10-29
PE20000264A1 (es) 2000-04-11
ATE370726T1 (de) 2007-09-15
CY1106970T1 (el) 2012-09-26

Similar Documents

Publication Publication Date Title
DK1052975T3 (da) Propofolsammensætning indeholdende sulfit
ATE300601T1 (de) Bleichmittelzusammensetzungen
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ATE295408T1 (de) Bleichmittelzusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
ID26186A (id) Komposisi sampo
ATE417099T1 (de) Bleichmittelzusammensetzungen enthaltend mehrfach substituierte protease varianten
ID29430A (id) Komposisi herbisida
DE69908252D1 (de) Geruchsmaskierte Dimethylsulfid-Zusammensetzung
BR9813566B1 (pt) composição biocida estabilizada contendo compostos de halopropinila.
DE69936208D1 (de) Modifiziermittel enthaltende zusammensetzung
DE69841155D1 (de) Emulsionzusammensetzung
DE69928862D1 (de) Zusammensetzung
ATE283332T1 (de) Propoxilat enthaltende kraftstoffzusammensetzungen
ATE260674T1 (de) Stabilisierte proteinzusammensetzung
ATE302839T1 (de) Bleichungzusammensetzungen
DE69809175D1 (de) Flavanon-enthaltende Zusammensetzungen
DE69800897D1 (de) Chemisch verstärkte Positiv-Resistzusammensetzung
FR2782522B1 (fr) Composition hydrofuge
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
DE69915683D1 (de) Emulsionszusammensetzungen
ATE307872T1 (de) Bleichmittelzusammensetzungen
FI990228L (fi) Paperinvalmistuksen lisäainekoostumus
DE69806145D1 (de) 3-alkylcycloalkanole enthaltende reichstoffkompositionen
ID22406A (id) Komposisi-komposisi umpan racun